More Articles
New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya® (somapacitan-beco) for three new…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and Drug Administration (FDA) approved…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February 27th, 2026, the FDA…
In Memoriam: Delbert A Fisher, MD (August 12, 1928 – March 4, 2026) Del Fisher, MD, one of the 38 founding members of our Society (formerly the Lawson Wilkins Pediatric…
March Historical Tidbit – Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In March 1922, Banting and Best published a preliminary report on the effect of subcutaneously…
Sahaj Singh, MD I am Sahaj Singh, a second-year pediatric endocrinology fellow at Texas Children’s Hospital, Baylor College of Medicine. I am originally from India, where I began my medical…
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA approved DESMODA™ (desmopressin acetate)…
Karen L. Clark, MMSc, PA‑C Karen L. Clark, MMSc, PA‑C, is an Advanced Practice Provider with more than 20 years of experience in pediatric endocrinology at St. Jude Children’s Research…
February Historical Tidbit: Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In February 1985, Ullrich et al reported the amino acid sequence of the insulin receptor precursor. This allowed for elucidation of the function…
